Pharmaceutical companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Grifols has the lowest figure of the 50 pharmaceutical companies ranked by P/S ratio, at 0.7, followed by Viatris (1.7) and GSK (2.2). Figures as of 18 Nov 2026, 19:11 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 50
- Lowest
- Grifols0.7
- Median
- 6.9
- Combined market value
- THB 172.3T
- Countries
- 10
- Not ranked
- 11no P/S ratio on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | GrifolsGRFS · Health Care | 0.7 | THB 194.7B | THB 286.11 | 2.38% down | 1% up | ||
| 2 | ViatrisVTRS · Health Care | 1.7 | THB 802.6B | THB 700.09 | 0.81% up | 96% up | ||
| 3 | GSKGSK · Health Care | 2.2 | THB 3.31T | THB 1,652.49 | 1.18% down | 6% up | ||
| 4 | SanofiSNY · Health Care | 2.3 | THB 3.85T | THB 1,604.95 | 0.57% down | 4% down | ||
| 5 | Takeda PharmaceuticalTAK · Health Care | 2.4 | THB 2.32T | THB 724.71 | 1.39% down | 54% up | ||
| 6 | Amneal PharmaceuticalsAMRX · Health Care | 2.5 | THB 260B | THB 746.27 | 4.05% up | 83% up | ||
| 7 | Bristol-Myers SquibbBMY · Health Care | 2.5 | THB 4.16T | THB 2,034.88 | 2.33% down | 34% up | ||
| 8 | PfizerPFE · Health Care | 2.6 | THB 5.44T | THB 953.77 | 1.35% down | 14% up | ||
| 9 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.8 | THB 1.67T | THB 1,428.53 | 1.30% down | 74% up | ||
| 10 | Elanco Animal HealthELAN · Health Care | 2.9 | THB 456.8B | THB 913.86 | 4.10% up | 20% up | ||
| 11 | PTC TherapeuticsPTCT · Health Care | 2.9 | THB 170.7B | THB 2,043.54 | 0.31% down | 20% down | ||
| 12 | Legend BiotechLEGN · Health Care | 3.0 | THB 106.4B | THB 548.79 | 0.31% up | 42% down | ||
| 13 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.5 | THB 425.7B | THB 510.59 | 1.66% up | 5% up | ||
| 14 | BioMarin PharmaceuticalBMRN · Health Care | 3.7 | THB 399.9B | THB 2,064.43 | 3.90% up | 11% up | ||
| 15 | ZoetisZTS · Health Care | 3.7 | THB 1.18T | THB 2,903.58 | 2.42% up | 29% down | ||
| 16 | Jazz PharmaceuticalsJAZZ · Health Care | 3.7 | THB 536.7B | THB 8,361.29 | 2.28% up | 37% up | ||
| 17 | Novo NordiskNVO · Health Care | 3.8 | THB 5.92T | THB 1,342.27 | 2.89% down | 17% down | ||
| 18 | Abbott LaboratoriesABT · Health Care | 4.1 | THB 6.15T | THB 3,548.48 | 0.21% down | 17% down | ||
| 19 | AstraZenecaAZN · Health Care | 4.7 | THB 9.43T | THB 6,077.31 | 1.82% down | 2% up | ||
| 20 | Ionis PharmaceuticalsIONS · Health Care | 4.9 | THB 157.3B | THB 944.43 | 3.15% up | 64% down | ||
| 21 | Merck & CoMRK · Health Care | 5.2 | THB 11.54T | THB 4,679.69 | 3.89% down | 51% up | ||
| 22 | AlkermesALKS · Health Care | 5.3 | THB 265.8B | THB 1,581.52 | 2.46% up | 58% up | ||
| 23 | Alnylam PharmaceuticalsALNY · Health Care | 5.4 | THB 678.6B | THB 5,066.83 | 4.66% down | 66% down | ||
| 24 | NovartisNVS · Health Care | 5.4 | THB 9.98T | THB 5,283.33 | 2.23% down | 25% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | 6.8 | THB 3.32T | THB 32,099.33 | 1.31% down | 36% up | ||
| 26 | Johnson & JohnsonJNJ · Health Care | 7.0 | THB 22.42T | THB 9,314.38 | 1.59% down | 38% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | THB 207.7B | THB 1,469.11 | 0.63% up | 10% up | ||
| 28 | United TherapeuticsUTHR · Health Care | 7.8 | THB 840.6B | THB 19,737.89 | 0.49% down | 23% up | ||
| 29 | AbbVieABBV · Health Care | 8.3 | THB 17.22T | THB 9,742.42 | 2.03% down | 26% up | ||
| 30 | GenmabGMAB · Health Care | 8.5 | THB 1.07T | THB 1,742.49 | 1.25% down | 70% up | ||
| 31 | BeOne MedicinesONC · Health Care | 8.6 | THB 1.57T | THB 13,724.59 | 2.21% down | 17% up | ||
| 32 | Madrigal PharmaceuticalsMDGL · Health Care | 9.7 | THB 316.5B | THB 13,624.24 | 4.93% down | 24% down | ||
| 33 | Corcept TherapeuticsCORT · Health Care | 9.7 | THB 252B | THB 2,302.15 | 3.25% down | 8% down | ||
| 34 | Travere TherapeuticsTVTX · Health Care | 9.9 | THB 165.4B | THB 1,722.79 | 0.72% down | 44% up | ||
| 35 | Axsome TherapeuticsAXSM · Health Care | 11.0 | THB 238.7B | THB 4,538.92 | 1.69% down | 7% down | ||
| 36 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.0 | THB 253.7B | THB 3,229.30 | 0.02% down | 126% up | ||
| 37 | Vertex PharmaceuticalsVRTX · Health Care | 11.4 | THB 4.63T | THB 18,272.18 | 0.72% up | 27% up | ||
| 38 | Mirum PharmaceuticalsMIRM · Health Care | 11.5 | THB 203.7B | THB 3,119.91 | 0.09% down | 31% up | ||
| 39 | TG TherapeuticsTGTX · Health Care | 16.2 | THB 338B | THB 2,236.27 | 5.01% up | 107% up | ||
| 40 | Royalty PharmaRPRX · Health Care | 16.8 | THB 1.35T | THB 2,353.94 | 0.92% up | 78% up | ||
| 41 | Eli LillyLLY · Health Care | 19.0 | THB 42.02T | THB 47,168.74 | 1.88% down | 35% up | ||
| 42 | Ascendis PharmaASND · Health Care | 22.2 | THB 603.2B | THB 9,195.52 | 0.15% down | 28% up | ||
| 43 | Ligand PharmaceuticalsLGND · Health Care | 22.4 | THB 204.3B | THB 10,213.64 | 2.36% up | 43% up | ||
| 44 | BridgeBio PharmaBBIO · Health Care | 30.2 | THB 514.5B | THB 2,641.24 | 1.27% up | 17% up | ||
| 45 | InsmedINSM · Health Care | 43.5 | THB 896.3B | THB 4,085.56 | 1.28% down | 40% down | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | 43.9 | THB 283.1B | THB 4,084.03 | 3.13% up | 13% up | ||
| 47 | CytokineticsCYTK · Health Care | 80.8 | THB 241.6B | THB 1,734.68 | 1.10% down | 20% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | 178 | THB 278.2B | THB 4,262.32 | 0.67% up | 46% up | ||
| 49 | Dianthus TherapeuticsDNTH · Health Care | 2392 | THB 165.4B | THB 2,936.86 | 0.57% down | 113% up | ||
| 50 | Roivant SciencesROIV · Health Care | 3367 | THB 944.4B | THB 1,303.38 | 0.85% down | 90% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 33.9600 THB). 11 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which pharmaceutical companies have the lowest P/S ratio?
Grifols (0.7), Viatris (1.7) and GSK (2.2) have the lowest P/S ratio of the 50 pharmaceutical companies ranked here as of 18 Nov 2026, 19:11 UTC.
How many pharmaceutical companies are in this ranking?
50 are ranked by P/S ratio. 11 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 50 pharmaceutical companies ranked by P/S ratio have a combined market value of THB 172.3T as of 18 Nov 2026, 19:11 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.